Daily as of 3 Nov 16:00 ET
- Price
- above both $20.75 vs 50 $18.94 / 200 $17.60
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 10 Aug 2026 · projected 6 bars out
TAK | Takeda Pharmaceutical CompanyNYSEADR golden cross and death cross projections, cross tests and history
$20.75
-$0.12 (-0.57%)
Takeda Pharmaceutical Company (TAK) is a NYSE-listed ADR that Cruxta has tracked for 50/200 crosses since 2019.
The 50 SMA has sat above the 200 on the daily since Aug 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $20.91 vs 50 $17.18 / 200 $15.26
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 29 Dec 2025 · projected 8 bars out
4-hour as of 3 Nov 13:30 ET
- Price
- above both $20.88 vs 50 $19.34 / 200 $17.86
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 4 Aug 2026 bar 2 · projected 19 bars out · tested 2 bars
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 10 Aug 2026 | 🟨Golden moderate | daily | 6 bars out | Not tested |
| 4 Aug 2026 | 🟨Golden | 4-hour | 19 bars out | 2 bar cross test |
| 3 Aug 2026 | 💀Death flat | daily | not projected | 1 bar cross test |
| 11 May 2026 | 💀Death | 4-hour | 30 bars out | Not tested |
| 14 Jan 2026 | 🟨Golden steep | daily | 27 bars out | Not tested |
About TAK
ExchangeNYSE
InstrumentADR
Median $ volume, 60 d$44.3M
4-hour coverageYes, since Oct 2025
History on recordSince 2019
Cap bandlarge